CRISPR-RELATED GENE THERAPY AGAINST SICKLE CELL DISEASE
FOR A BRIGHTER TOMORROW
The number of patients with sickle cell disease in the European Union exceeds 52 thousand. CRISPR-related gene therapy will reduce the burden on the healthcare system and provide a more effective allocation of healthcare resources.
From the research-based pharmaceutical industry in Europe.